Kerri Schoedel, Ph.D. has been promoted to scientific director, clinical pharmacology for Kendle’s Early Stage unit in Toronto. Dr. Schoedel will provide overall scientific direction and leadership to the clinical pharmacology group, as well as lead strategic planning and policy development as it relates to scientific assessment.  She is experienced in the field of psychopharmacology and the assessment of drug abuse liability, and also has experience in pre-clinical and clinical studies an...